Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-03-01

AUTHORS

O Blennow, M Remberger, L Klingspor, B Omazic, K Fransson, P Ljungman, J Mattsson, O Ringdén

ABSTRACT

Invasive fungal infections (IFIs) are major complications after allogeneic hematopoietic SCT (HSCT). PCR-based assays able to detect fungal DNA have been reported to precede clinical diagnosis of IFI. We performed a prospective study to evaluate a PCR-based pre-emptive approach. Ninety-nine patients undergoing reduced-intensity conditioning (RIC) HSCT were followed with fungal PCR during the first 100 days post transplantation. Patients who tested positive were randomized to receive liposomal amphotericin B, or to no intervention. After day 100, PCR tests were performed only on clinical suspicion of IFI. A single positive PCR test was not associated with IFI, irrespective of treatment. After day 100, PCR tests for Aspergillus did not contribute to diagnosis of invasive aspergillosis (IA). The cumulative incidence rates of proven or probable IA during the first year after transplantation were 9%. GVHD grades II–IV (P=0.0014), CMV-seronegative recipient with CMV-seropositive donor (P⩽0.001), and conditioning with alemtuzumab (P=0.014) were significant risk factors for developing IA in a multivariate model. In this study, PCR on peripheral blood was a poor indicator of IFI early after RIC HSCT. Aspergillus PCR tests performed on clinical suspicion after day 100 were insufficiently sensitive to be diagnostically useful. More... »

PAGES

1710-1718

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bmt.2010.38

DOI

http://dx.doi.org/10.1038/bmt.2010.38

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050011141

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20190840


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amphotericin B", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antifungal Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aspergillosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aspergillus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Candida", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Candidiasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mycoses", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Infectious Diseases, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.4714.6", 
          "name": [
            "Division of Infectious Diseases, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Blennow", 
        "givenName": "O", 
        "id": "sg:person.0762254562.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762254562.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Immunology and Transfusion Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.4714.6", 
          "name": [
            "Department of Clinical Immunology and Transfusion Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Remberger", 
        "givenName": "M", 
        "id": "sg:person.0646371511.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646371511.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Bacteriology, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.4714.6", 
          "name": [
            "Division of Clinical Bacteriology, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Klingspor", 
        "givenName": "L", 
        "id": "sg:person.01225075567.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225075567.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Allogeneic Stem Cell Transplantation, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.4714.6", 
          "name": [
            "Center for Allogeneic Stem Cell Transplantation, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Omazic", 
        "givenName": "B", 
        "id": "sg:person.01360040365.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360040365.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Allogeneic Stem Cell Transplantation, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.4714.6", 
          "name": [
            "Center for Allogeneic Stem Cell Transplantation, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fransson", 
        "givenName": "K", 
        "id": "sg:person.0662407107.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0662407107.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Haematology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.4714.6", 
          "name": [
            "Department of Haematology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ljungman", 
        "givenName": "P", 
        "id": "sg:person.01077046511.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077046511.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Allogeneic Stem Cell Transplantation, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.4714.6", 
          "name": [
            "Center for Allogeneic Stem Cell Transplantation, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mattsson", 
        "givenName": "J", 
        "id": "sg:person.0714504711.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714504711.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Allogeneic Stem Cell Transplantation, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.4714.6", 
          "name": [
            "Center for Allogeneic Stem Cell Transplantation, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ringd\u00e9n", 
        "givenName": "O", 
        "id": "sg:person.01145161711.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145161711.84"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00520-005-0903-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001206031", 
          "https://doi.org/10.1007/s00520-005-0903-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1703811", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052699974", 
          "https://doi.org/10.1038/sj.bmt.1703811"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1704768", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049437959", 
          "https://doi.org/10.1038/sj.bmt.1704768"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1705825", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018484569", 
          "https://doi.org/10.1038/sj.bmt.1705825"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-03-01", 
    "datePublishedReg": "2010-03-01", 
    "description": "Invasive fungal infections (IFIs) are major complications after allogeneic hematopoietic SCT (HSCT). PCR-based assays able to detect fungal DNA have been reported to precede clinical diagnosis of IFI. We performed a prospective study to evaluate a PCR-based pre-emptive approach. Ninety-nine patients undergoing reduced-intensity conditioning (RIC) HSCT were followed with fungal PCR during the first 100 days post transplantation. Patients who tested positive were randomized to receive liposomal amphotericin B, or to no intervention. After day 100, PCR tests were performed only on clinical suspicion of IFI. A single positive PCR test was not associated with IFI, irrespective of treatment. After day 100, PCR tests for Aspergillus did not contribute to diagnosis of invasive aspergillosis (IA). The cumulative incidence rates of proven or probable IA during the first year after transplantation were 9%. GVHD grades II\u2013IV (P=0.0014), CMV-seronegative recipient with CMV-seropositive donor (P\u2a7d0.001), and conditioning with alemtuzumab (P=0.014) were significant risk factors for developing IA in a multivariate model. In this study, PCR on peripheral blood was a poor indicator of IFI early after RIC HSCT. Aspergillus PCR tests performed on clinical suspicion after day 100 were insufficiently sensitive to be diagnostically useful.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/bmt.2010.38", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "45"
      }
    ], 
    "keywords": [
      "invasive fungal infections", 
      "hematopoietic SCT", 
      "invasive aspergillosis", 
      "day 100", 
      "clinical suspicion", 
      "PCR test", 
      "risk factors", 
      "fungal infections", 
      "CMV-seronegative recipients", 
      "CMV-seropositive donors", 
      "allogeneic hematopoietic SCT", 
      "probable invasive aspergillosis", 
      "reduced-intensity conditioning", 
      "cumulative incidence rate", 
      "days post transplantation", 
      "liposomal amphotericin B", 
      "positive PCR test", 
      "significant risk factors", 
      "major complications", 
      "post transplantation", 
      "prospective study", 
      "peripheral blood", 
      "pre-emptive approach", 
      "incidence rate", 
      "amphotericin B", 
      "clinical diagnosis", 
      "fungal PCR", 
      "multivariate model", 
      "patients", 
      "transplantation", 
      "infection", 
      "suspicion", 
      "first year", 
      "diagnosis", 
      "PCR", 
      "SCT", 
      "GVHD", 
      "alemtuzumab", 
      "complications", 
      "aspergillosis", 
      "poor indicator", 
      "therapy", 
      "blood", 
      "recipients", 
      "intervention", 
      "test", 
      "treatment", 
      "factors", 
      "study", 
      "assays", 
      "fungal DNA", 
      "years", 
      "donors", 
      "Aspergillus", 
      "rate", 
      "conditioning", 
      "DNA", 
      "indicators", 
      "model", 
      "approach"
    ], 
    "name": "Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT", 
    "pagination": "1710-1718", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050011141"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bmt.2010.38"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20190840"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bmt.2010.38", 
      "https://app.dimensions.ai/details/publication/pub.1050011141"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_517.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/bmt.2010.38"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.38'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.38'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.38'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.38'


 

This table displays all metadata directly associated to this object as RDF triples.

278 TRIPLES      21 PREDICATES      110 URIs      98 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bmt.2010.38 schema:about N0645012bb44042c3bd0a65514ec4311d
2 N1623bf84525e4ede86476c8374e1c091
3 N17e5ad89b4a34b03ab55cf881aabc417
4 N246ec2f4b59e4feeb96823620640081f
5 N34a0c947b8e64422adaae6ebaf557672
6 N3a614a241c9f49cb9264597cd821f0cf
7 N4bf4b218eea94337a609b8a7b7735607
8 N4ddda1ac768d4e698d3466611f22b6e9
9 N635123c6fca04ee7815750839945e1d7
10 N6deb0b4e81bf4109b25c7aa70361c88c
11 N939f98dea63a4e3d8129c5c467578234
12 Nac4a72372ad74693ab728c67efe5d92e
13 Nae95bc7f7a424e438da21cd8806ad1fe
14 Nbdfb6953af0c43a3b518eadb32b7cc1a
15 Nc550386a7d744263ae5119122030ecfb
16 Nc8caefe29b42412aac16625b89c9de45
17 Nd0d0c082e4c047f2b6ff2ed6ae7c0a7a
18 Ndd9643e0a68e45a89cdc40e00d24f06b
19 Nde4bcc5ade574ea19ceef2f244e410cd
20 Nf2b03e3b365f44a6b075bff813290f4d
21 Nf674347592ca48da87524de2bc7d74ff
22 anzsrc-for:11
23 anzsrc-for:1103
24 schema:author Nde8a1fba68024285b04d90ec3421a0d4
25 schema:citation sg:pub.10.1007/s00520-005-0903-7
26 sg:pub.10.1038/sj.bmt.1703811
27 sg:pub.10.1038/sj.bmt.1704768
28 sg:pub.10.1038/sj.bmt.1705825
29 schema:datePublished 2010-03-01
30 schema:datePublishedReg 2010-03-01
31 schema:description Invasive fungal infections (IFIs) are major complications after allogeneic hematopoietic SCT (HSCT). PCR-based assays able to detect fungal DNA have been reported to precede clinical diagnosis of IFI. We performed a prospective study to evaluate a PCR-based pre-emptive approach. Ninety-nine patients undergoing reduced-intensity conditioning (RIC) HSCT were followed with fungal PCR during the first 100 days post transplantation. Patients who tested positive were randomized to receive liposomal amphotericin B, or to no intervention. After day 100, PCR tests were performed only on clinical suspicion of IFI. A single positive PCR test was not associated with IFI, irrespective of treatment. After day 100, PCR tests for Aspergillus did not contribute to diagnosis of invasive aspergillosis (IA). The cumulative incidence rates of proven or probable IA during the first year after transplantation were 9%. GVHD grades II–IV (P=0.0014), CMV-seronegative recipient with CMV-seropositive donor (P⩽0.001), and conditioning with alemtuzumab (P=0.014) were significant risk factors for developing IA in a multivariate model. In this study, PCR on peripheral blood was a poor indicator of IFI early after RIC HSCT. Aspergillus PCR tests performed on clinical suspicion after day 100 were insufficiently sensitive to be diagnostically useful.
32 schema:genre article
33 schema:isAccessibleForFree false
34 schema:isPartOf N1d4263d6c33e4ab0b6a59049694be123
35 N4322b820da0d42b4ae7398842238cd3a
36 sg:journal.1096890
37 schema:keywords Aspergillus
38 CMV-seronegative recipients
39 CMV-seropositive donors
40 DNA
41 GVHD
42 PCR
43 PCR test
44 SCT
45 alemtuzumab
46 allogeneic hematopoietic SCT
47 amphotericin B
48 approach
49 aspergillosis
50 assays
51 blood
52 clinical diagnosis
53 clinical suspicion
54 complications
55 conditioning
56 cumulative incidence rate
57 day 100
58 days post transplantation
59 diagnosis
60 donors
61 factors
62 first year
63 fungal DNA
64 fungal PCR
65 fungal infections
66 hematopoietic SCT
67 incidence rate
68 indicators
69 infection
70 intervention
71 invasive aspergillosis
72 invasive fungal infections
73 liposomal amphotericin B
74 major complications
75 model
76 multivariate model
77 patients
78 peripheral blood
79 poor indicator
80 positive PCR test
81 post transplantation
82 pre-emptive approach
83 probable invasive aspergillosis
84 prospective study
85 rate
86 recipients
87 reduced-intensity conditioning
88 risk factors
89 significant risk factors
90 study
91 suspicion
92 test
93 therapy
94 transplantation
95 treatment
96 years
97 schema:name Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT
98 schema:pagination 1710-1718
99 schema:productId N10180034f61043d285df33a89d31dada
100 N15480be5b57a4d69af7fe91236c55174
101 Nc29f9a8c486d4d0aa3b368f8a3e05909
102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050011141
103 https://doi.org/10.1038/bmt.2010.38
104 schema:sdDatePublished 2022-11-24T20:54
105 schema:sdLicense https://scigraph.springernature.com/explorer/license/
106 schema:sdPublisher N26e8584fcfcb409f91aa7e99eb313227
107 schema:url https://doi.org/10.1038/bmt.2010.38
108 sgo:license sg:explorer/license/
109 sgo:sdDataset articles
110 rdf:type schema:ScholarlyArticle
111 N0645012bb44042c3bd0a65514ec4311d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Aspergillus
113 rdf:type schema:DefinedTerm
114 N09bbfe23a3d74b4a818dd8bb34ea74d0 rdf:first sg:person.0646371511.36
115 rdf:rest Nd53e1cd5f4bf4f46b15ded2dbd611569
116 N0c4479cc3fc547328d27073fcb357474 rdf:first sg:person.01360040365.08
117 rdf:rest Naf37730aebe74589b1968b0bb952a955
118 N10180034f61043d285df33a89d31dada schema:name dimensions_id
119 schema:value pub.1050011141
120 rdf:type schema:PropertyValue
121 N15480be5b57a4d69af7fe91236c55174 schema:name doi
122 schema:value 10.1038/bmt.2010.38
123 rdf:type schema:PropertyValue
124 N1623bf84525e4ede86476c8374e1c091 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Hematopoietic Stem Cell Transplantation
126 rdf:type schema:DefinedTerm
127 N17e5ad89b4a34b03ab55cf881aabc417 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Adolescent
129 rdf:type schema:DefinedTerm
130 N1d4263d6c33e4ab0b6a59049694be123 schema:volumeNumber 45
131 rdf:type schema:PublicationVolume
132 N246ec2f4b59e4feeb96823620640081f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Candidiasis
134 rdf:type schema:DefinedTerm
135 N26e8584fcfcb409f91aa7e99eb313227 schema:name Springer Nature - SN SciGraph project
136 rdf:type schema:Organization
137 N3496d7b416444ed49afbf4cefd1214c3 rdf:first sg:person.0714504711.87
138 rdf:rest Nef74624d82ce49dc8b05a947fc402a37
139 N34a0c947b8e64422adaae6ebaf557672 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Amphotericin B
141 rdf:type schema:DefinedTerm
142 N3a614a241c9f49cb9264597cd821f0cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Child
144 rdf:type schema:DefinedTerm
145 N4322b820da0d42b4ae7398842238cd3a schema:issueNumber 12
146 rdf:type schema:PublicationIssue
147 N4bf4b218eea94337a609b8a7b7735607 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Candida
149 rdf:type schema:DefinedTerm
150 N4ddda1ac768d4e698d3466611f22b6e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Young Adult
152 rdf:type schema:DefinedTerm
153 N635123c6fca04ee7815750839945e1d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Female
155 rdf:type schema:DefinedTerm
156 N6deb0b4e81bf4109b25c7aa70361c88c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Polymerase Chain Reaction
158 rdf:type schema:DefinedTerm
159 N939f98dea63a4e3d8129c5c467578234 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Treatment Outcome
161 rdf:type schema:DefinedTerm
162 Nac4a72372ad74693ab728c67efe5d92e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Male
164 rdf:type schema:DefinedTerm
165 Nae95bc7f7a424e438da21cd8806ad1fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Risk Factors
167 rdf:type schema:DefinedTerm
168 Naf37730aebe74589b1968b0bb952a955 rdf:first sg:person.0662407107.35
169 rdf:rest Nc6bce9651e104f35a17d672cc62ec815
170 Nbdfb6953af0c43a3b518eadb32b7cc1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Humans
172 rdf:type schema:DefinedTerm
173 Nc29f9a8c486d4d0aa3b368f8a3e05909 schema:name pubmed_id
174 schema:value 20190840
175 rdf:type schema:PropertyValue
176 Nc550386a7d744263ae5119122030ecfb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Mycoses
178 rdf:type schema:DefinedTerm
179 Nc6bce9651e104f35a17d672cc62ec815 rdf:first sg:person.01077046511.37
180 rdf:rest N3496d7b416444ed49afbf4cefd1214c3
181 Nc8caefe29b42412aac16625b89c9de45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Antifungal Agents
183 rdf:type schema:DefinedTerm
184 Nd0d0c082e4c047f2b6ff2ed6ae7c0a7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Adult
186 rdf:type schema:DefinedTerm
187 Nd53e1cd5f4bf4f46b15ded2dbd611569 rdf:first sg:person.01225075567.37
188 rdf:rest N0c4479cc3fc547328d27073fcb357474
189 Ndd9643e0a68e45a89cdc40e00d24f06b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Aspergillosis
191 rdf:type schema:DefinedTerm
192 Nde4bcc5ade574ea19ceef2f244e410cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Prospective Studies
194 rdf:type schema:DefinedTerm
195 Nde8a1fba68024285b04d90ec3421a0d4 rdf:first sg:person.0762254562.21
196 rdf:rest N09bbfe23a3d74b4a818dd8bb34ea74d0
197 Nef74624d82ce49dc8b05a947fc402a37 rdf:first sg:person.01145161711.84
198 rdf:rest rdf:nil
199 Nf2b03e3b365f44a6b075bff813290f4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Middle Aged
201 rdf:type schema:DefinedTerm
202 Nf674347592ca48da87524de2bc7d74ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Aged
204 rdf:type schema:DefinedTerm
205 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
206 schema:name Medical and Health Sciences
207 rdf:type schema:DefinedTerm
208 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
209 schema:name Clinical Sciences
210 rdf:type schema:DefinedTerm
211 sg:journal.1096890 schema:issn 0268-3369
212 1476-5365
213 schema:name Bone Marrow Transplantation
214 schema:publisher Springer Nature
215 rdf:type schema:Periodical
216 sg:person.01077046511.37 schema:affiliation grid-institutes:grid.4714.6
217 schema:familyName Ljungman
218 schema:givenName P
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077046511.37
220 rdf:type schema:Person
221 sg:person.01145161711.84 schema:affiliation grid-institutes:grid.4714.6
222 schema:familyName Ringdén
223 schema:givenName O
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145161711.84
225 rdf:type schema:Person
226 sg:person.01225075567.37 schema:affiliation grid-institutes:grid.4714.6
227 schema:familyName Klingspor
228 schema:givenName L
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225075567.37
230 rdf:type schema:Person
231 sg:person.01360040365.08 schema:affiliation grid-institutes:grid.4714.6
232 schema:familyName Omazic
233 schema:givenName B
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360040365.08
235 rdf:type schema:Person
236 sg:person.0646371511.36 schema:affiliation grid-institutes:grid.4714.6
237 schema:familyName Remberger
238 schema:givenName M
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646371511.36
240 rdf:type schema:Person
241 sg:person.0662407107.35 schema:affiliation grid-institutes:grid.4714.6
242 schema:familyName Fransson
243 schema:givenName K
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0662407107.35
245 rdf:type schema:Person
246 sg:person.0714504711.87 schema:affiliation grid-institutes:grid.4714.6
247 schema:familyName Mattsson
248 schema:givenName J
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714504711.87
250 rdf:type schema:Person
251 sg:person.0762254562.21 schema:affiliation grid-institutes:grid.4714.6
252 schema:familyName Blennow
253 schema:givenName O
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762254562.21
255 rdf:type schema:Person
256 sg:pub.10.1007/s00520-005-0903-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001206031
257 https://doi.org/10.1007/s00520-005-0903-7
258 rdf:type schema:CreativeWork
259 sg:pub.10.1038/sj.bmt.1703811 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052699974
260 https://doi.org/10.1038/sj.bmt.1703811
261 rdf:type schema:CreativeWork
262 sg:pub.10.1038/sj.bmt.1704768 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049437959
263 https://doi.org/10.1038/sj.bmt.1704768
264 rdf:type schema:CreativeWork
265 sg:pub.10.1038/sj.bmt.1705825 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018484569
266 https://doi.org/10.1038/sj.bmt.1705825
267 rdf:type schema:CreativeWork
268 grid-institutes:grid.4714.6 schema:alternateName Center for Allogeneic Stem Cell Transplantation, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
269 Department of Clinical Immunology and Transfusion Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
270 Department of Haematology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
271 Division of Clinical Bacteriology, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
272 Division of Infectious Diseases, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
273 schema:name Center for Allogeneic Stem Cell Transplantation, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
274 Department of Clinical Immunology and Transfusion Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
275 Department of Haematology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
276 Division of Clinical Bacteriology, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
277 Division of Infectious Diseases, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
278 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...